Price Chart

Profile

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
URL https://www.bms.com
Investor Relations URL https://www.bms.com/investors.html
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Value
Next Earnings Release Apr. 25, 2024
Last Earnings Release Feb. 02, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jan. 04, 2024

Profile

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
URL https://www.bms.com
Investor Relations URL https://www.bms.com/investors.html
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Value
Next Earnings Release Apr. 25, 2024
Last Earnings Release Feb. 02, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jan. 04, 2024